The roles of community pharmacists in managing patients with diabetes: Perceptions of health care professionals in Nova Scotia

Canadian Pharmacists Journal

Volumn 138, Issue 6, 2005, Pages 46-53

  Hartnell, Nicole R ^a   MacKinnon, Neil J ^a   Sketris, Ingrid S ^a   Gass, David ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b Nova Scotia Department of Health   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

CANADA; COMMUNITY CARE; DIABETES CONTROL; DIABETES MELLITUS; DIETITIAN; GLUCOSE BLOOD LEVEL; HEALTH CARE PERSONNEL; HUMAN; LIFESTYLE; NURSE; PATIENT CARE; PATIENT EDUCATION; PATIENT MONITORING; PERCEPTION; PHARMACIST; PRIMARY HEALTH CARE; REVIEW; SELF MONITORING;

EID: 26244441936     PISSN: 17151635     EISSN: None     Source Type: Journal    
DOI: 10.1177/171516350513800611     Document Type: Review

References (34)

1. Colman R. The cost of chronic disease in Nova Scotia. Glen Haven (NS): GPI Atlantic; 2002. Available: www.gov.ns.ca/ health/downloads/chronic.pdf (accessed April 8, 2003).
2. Harvey D, Hood E, McCutcheon V, et al. Chronic disease prevention: a worthwhile investment. Winnipeg, Manitoba: Alliance for the Prevention of Chronic Disease; 1996. Available: www.apcd.mb.ca/pdfs/a_worthwhile_investment. pdf (accessed July 11, 2005).
3. Meltzer S, Leiter L, Daneman D, et al. 1998 clinical practice guidelines for the management of diabetes in Canada. CMAJ 1998;159(8Suppl):S1-29.
4. Campbell RK. DCCT opens new opportunities for pharmacists. Calif Pharm 1993;Dec:26-7.
5. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
6. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103-17.
7. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
8. Erratum in: Lancet 1999;354:602.
9. Berringer R, Shibley MCH, Cary G, et al. Outcomes of a community pharmacy-based diabetes monitoring program. J Am Pharm Assoc 1999;39:791-7.
10. Schapansky LM, Johnson JA, Majumdar SR, et al. The burden of pharmacotherapy for patients with type 2 diabetes in northern Alberta - data from the DOVE Study [abstract]. Can J Clin Pharmacol 2001;8(1):22.
11. Cranor C, Christensen D. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc 2003;43(2):149-59.
12. Cherry JC, Moffatt TP, Rodriquez C, Dryden K. Diabetes disease management program for an indigent population empowered by telemedicine technology. Diabetes Technol Ther 2002; 4(6):783-91.
13. Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilization, costs and patient outcomes [Cochrane review]. In: The Cochrane Library, Issue 4, 2003. Chichester (UK): John Wiley & Sons, Ltd.
14. Walker DR, Landis DL, Stern PM, Vance RP. Disease management positively affects patient quality of life. Manag Care Interface 2003;16(4):56-60.
15. Nahata MC. Pharmacist's role in health care [editorial]. Ann Pharmacother 2002;36:527-9.
16. Crabtree BF, Miller WL, editors. Doing qualitative research. 2nd ed. Thousand Oaks (CA): Sage Publications; 1999.
17. Welcome to Capital Health [website]. Halifax: Capital Health. Available: www.cdha.nshealth.ca/ (accessed August 31, 2004).
18. Physician search [online database]. Halifax: College of Physicians and Surgeons of Nova Scotia; updated May 13, 2005. Available: http://server1. kljsolutions.com/pr2/search.asp (accessed May 17, 2005).
19. Pharmacy Association of Nova Scotia - welcome [home page]. Halifax: The Association. Available: www.pans.ns.ca/ (accessed July 12, 2003).
20. Hurricane Juan. September 28 & 29, 2003 [website]. Ottawa: Environment Canada. Available: www.atl.ec.gc.ca/weather/hurricane/juan/ (accessed September 2, 2004).
21. Campbell RK. Role of the pharmacist in diabetes management. Am J Health Syst Pharm 2002;59(Suppl 9):S18-21.
22. American Society of Health-System Pharmacists. ASHP statement on the pharmacist's role in primary care. Am J Health Syst Pharm 1999;56:1655-67.
23. Johnson T. Diabetes care, pharmacy practice. In: DiPiro JT, editor. Encyclopedia of Clinical Pharmacy. New York: Marcel Dekker, Inc; 2003: 256-7.
24. Schapansky LM, Johnson JA. Pharmacists' attitudes toward diabetes. J Am Pharm Assoc 2000;40(3):371-7.
25. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
26. Speaking notes for Commissioner Roy Romanow Commission on the Future of Health Care in Canada at the Canadian Pharmacists Association conference "Rising from the plains, pharmacists practisting excellence"; Winnipeg; May 13, 2002. Available: www.pharmacists.ca/content/about_cpha/whats_ happening/CPhA_in_action/pdf/romanow_speech_at_cpha_co nference.pdf (accessed May 12, 2003).
27. CMA policy summary. Approaches to enhancing the quality of drug therapy. A joint statement by the CMA and the Candian Pharmaceutical Association. CMAJ 1996;155(6):784A-C.
28. Bradshaw SJ, Doucette WR. Community pharmacists as patient advocates: physician attitudes. J Am Pharm Assoc 1998; 38(5):598-602.
29. Ranelli PL, Biss J. Physician's perceptions of communication with and responsibilities of pharmacists. J Am Pharm Assoc 2000;40(5):625-30.
30. American College of Physicians, American Society of Internal Medicine. Pharmacist scope of practice [position paper]. Ann Intern Med 2002;136:79-85.
31. MacKinnon NJ, Zwicker LA. Review of seamless care - backgrounder. In: MacKinnon NJ, editor. Seamless care: a pharmacist's guide to continuous care programs. Ottawa: Canadian Pharmacists Association; 2003:1-12.
32. Dossa A. Overcoming barriers to seamless care. In: MacKinnon NJ, editor. Seamless care: a pharmacist's guide to continuous care programs. Ottawa: Canadian Pharmacists Association; 2003:19-29.
33. Bandura A. Self-effiacy theory: toward a unifying theory of behavioral change. Psychol Rev 1977;84(2):191-215.
34. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process 1991;50:179-211.